Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)

NCT00660764 · clinicaltrials.gov ↗

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia
Coronary Heart Disease
Peripheral Vascular Disease
Cerebrovascular Accident
Diabetes

Interventions

DRUG: Rosuvastatin

Sponsor

AstraZeneca